# US 2012/0253238 A1 · Compositions for solubilizing cells and/or tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253238 A1
- Document ID: US20120253238A1
- Status: Published application
- Kind: A1
- Application number: 13/473,261
- Filed: 2012-05-16
- Published: 2012-10-04
- Earliest claimed: 2007-08-06
- Inventors: Samir Mitragotri; Russell M. Lebovitz; Beyeong Hee Hwang
- Web page: https://patentgrep.com/patent/US20120253238A1

## CPC

- A61B 5/443: {Evaluating skin constituents, e.g. elastin, melanin, water}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 10/02: Instruments for taking cell samples or for biopsy {(A61B10/0038 and A61B10/0045 take precedence; needle locating or guiding means A61B17/3403; samplers for enzymology or microbiology C12M1/26; sampling or preparing biological specimens G01N33/48)}
- A61B 18/06: caused by chemical reaction {, e.g. moxaburners}
- A61K 9/0009: {involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K 31/08: acyclic, e.g. paraformaldehyde
- A61K 31/205: Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A61K 31/765: Polymers containing oxygen
- A61P 17/00: Drugs for dermatological disorders
- C07J 9/00: Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07K 16/18: against material from animals or humans
- C12Q 1/32: involving dehydrogenase
- A61B 2018/00458: {Deeper parts of the skin, e.g. treatment of vascular disorders or port wine stains}
- C07K 2317/52: Constant or Fc region; Isotype
- C07K 2317/94: Stability, e.g. half-life, pH, temperature or enzyme-resistance
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07J: STEROIDS (seco-steroids C07C)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Solubilizing compositions are provided. The compositions comprise at least one zwitterionic surfactant and at least one nonionic surfactant. In one embodiment, the compositions may be useful for solubilizing and remodeling and/or removing tissue on or beneath a patient's skin, optionally in conjunction with the application of energy to a region of interest on the skin. In one embodiment, at least one analyte may be collected and analyzed from the solubilized tissue.

## Claims

### Claim 1

A composition, comprising:
a zwitterionic surfactant, comprising:
wherein n is selected from 10, 12, 14, 16, and 18; and
a non-ionic surfactant, comprising:
H(CH2)aO(CH2CH2O)bH
wherein a is selected from 12 and 16, and wherein b is selected from 2, 4, 10, 20, and 23,
with the provisos that:
(i) when n is 10, a and b are not, together respectively, 12 and 4; and
(ii) when n is 16, a and b are not, together respectively, 12 and 23.

### Claim 2 (depends on 1)

The composition of claim 1, wherein n is 12, a is 16, and b is 10.

### Claim 3 (depends on 1)

The composition of claim 1, wherein n is 14, a is 12, and b is 4.

### Claim 4 (depends on 1)

The composition of claim 1, wherein n is 14, a is 16, and b is 2.

### Claim 5 (depends on 1)

The composition of claim 1, wherein n is 14, a is 16, and b is 10.

### Claim 6 (depends on 1)

The composition of claim 1, wherein n is 16, a is 12, and b is 4.

### Claim 7 (depends on 1)

The composition of claim 1, wherein n is 16, a is 16, and b is 2.

### Claim 8 (depends on 1)

The composition of claim 1, wherein n is 16, a is 16, and b is 10.

### Claim 9 (depends on 1)

The composition of claim 1, wherein n is 18, a is 12, and b is 4.

### Claim 10 (depends on 1)

The composition of claim 1, wherein n is 18, a is 16, and b is 2.

### Claim 11 (depends on 1)

The composition of claim 1, wherein n is 18, a is 16, and b is 10.

### Claim 12 (depends on 1)

The composition of claim 1, wherein n is 18, a is 16, and b is 20.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the composition has a pH more basic than about 7.0 in a buffer solution.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the composition has a pH of between about 7.0 and about 9.0 in a buffer solution.

### Claim 15

A method for solubilizing and remodeling and/or removing tissue on or beneath a patient's skin, the method comprising:
applying energy to a region of interest on the skin; and
contacting the region with a tissue solubilizing composition, the tissue solubilizing composition comprising:
a zwitterionic surfactant, comprising:
wherein n is selected from 10, 12, 14, 16, and 18; and
a non-ionic surfactant, comprising:
H(CH2)aO(CH2CH2O)bH
wherein a is selected from 12 and 16, and wherein b is selected from 2, 4, 10, 20, and 23,
with the proviso that when n is 10, a and b are not, together respectively, 12 and 4.

### Claim 16 (depends on 15)

The method of claim 15, further comprising:
removing at least a portion of the solubilized region of interest to leave an exposed area on the skin; and
applying to the exposed area at least one of a therapeutic composition and a cosmetic composition.

### Claim 17 (depends on 16)

The method of claim 16, wherein the applying comprises applying to the exposed area a therapeutic composition comprising at least one of a DNA-based drug, an RNA-based drug, a protein-based drug, a peptide-based drug, a lipid-based drug, a carbohydrate-based drug, a small molecule drug, a nanoparticle-based drug, and a liposome-encapsulated drug.

### Claim 18 (depends on 16)

The method of claim 16, wherein the applying comprises applying to the exposed area a cosmetic composition comprising at least one of elastin, an elastin-based peptide, collagen, a collagen-based peptide, resveratrol, idebenone, co-enzyme Q10, acetyl hexapeptide-3, glycosaminoglycans, palmitoyl pentapeptide-4, sodium hyaluronate, and combinations thereof.

### Claim 19

A method for recovering analytes from mucosal membrane, skin, or other tissue, the method comprising:
applying energy to a region of interest on the mucosal membrane, skin, or other tissue containing at least one analyte;
contacting the region with a tissue solubilizing composition, thereby solubilizing at least some of the mucosal membrane, skin, or other tissue containing at least one analyte, wherein the tissue solubilizing composition comprises:
a zwitterionic surfactant, comprising:
wherein n is selected from 10, 12, 14, 16, and 18; and
a non-ionic surfactant, comprising:
H(CH2)aO(CH2CH2O)bH
wherein a is selected from 12 and 16, and wherein b is selected from 2, 4, 10, 20, and 23,
with the proviso that when n is 10, a and b are not, together respectively, 12 and 4; and
collecting the at least one analyte from the solubilized mucosal membrane, skin, and other tissue.

### Claim 20 (depends on 19)

The method of claim 19, wherein the analyte comprises a protein.

### Claim 21 (depends on 19)

The method of claim 19, wherein the analyte comprises a cancer biomarker.

### Claim 22 (depends on 19)

The method of claim 19, wherein the analyte comprises an antibody.

### Claim 23 (depends on 19)

The method of claim 19, wherein the analyte comprises a peptide.

### Claim 24 (depends on 19)

The method of claim 19, wherein the analyte comprises a lipid.

### Claim 25 (depends on 19)

The method of claim 19, wherein the analyte comprises a nucleic acid.

### Claim 26 (depends on 19)

The method of claim 19, wherein the analyte comprises a small molecule.

### Claim 27 (depends on 19)

The method of claim 19, wherein the analyte comprises a microbe.

### Claim 28 (depends on 19)

The method of claim 19, wherein the analyte comprises a warfare agent.

### Claim 29 (depends on 19)

The method of claim 19, wherein the analyte comprises an environmental contaminant.

### Claim 30 (depends on 19)

The method of claim 19, wherein the analyte comprises a drug.
